Reply
J Hypertens
.
2021 May 1;39(5):1045-1046.
doi: 10.1097/HJH.0000000000002781.
Authors
Katy Bell
1
,
Jenny Doust
2
,
Kevin McGeechan
1
,
Andrea R Horvath
3
,
Alexandra Barratt
1
,
Andrew Hayen
4
,
Christopher Semsarian
5
6
7
,
Les Irwig
1
Affiliations
1
Wiser Healthcare, School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales.
2
Institute for Evidence-Based Healthcare (IEBH), Faculty of Health Sciences and Medicine, Bond University, Robina, Queensland.
3
Department of Clinical Chemistry and Endocrinology, New South Wales Health Pathology.
4
Australian Centre for Public and Population Health Research, University of Technology Sydney (UTS).
5
Agnes Ginges Centre for Molecular Cardiology at Centenary Institute.
6
Sydney Medical School, Faculty of Medicine and Health, The University of Sydney.
7
Department of Cardiology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
PMID:
33824261
DOI:
10.1097/HJH.0000000000002781
No abstract available
Publication types
Letter
Comment